Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENDS (ENDometriosis & FuSobacterium) Unveiling the Contribution of Fusobacterium Infection to the Development of Endometriosis

NCT06368596 is registered in ClinicalTrials.gov with IRCCS Sacro Cuore Don Calabria di Negrar as lead sponsor.

NCT NCT06368596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06368596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENDS (ENDometriosis & FuSobacterium) Unveiling the Contribution of Fusobacterium Infection to the Development of Endometriosis
Lead sponsor
IRCCS Sacro Cuore Don Calabria di Negrar
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2024
Completion date
October 31, 2025
Enrollment
845 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometriosis